Alta-innovations news
- Description
- Irresistible Materials (IM), a UK materials technology company spun-out from the University of Birmingham, is pleased to announce £290,000 of further support from its investing shareholder (Mercia Fund Management) and new business angels from the US and UK, coupled with the appointment of Stuart McIntosh as its new Chairman.
- Date:
- 20/05/2013
- Description
- OXFORD, UK – 8th May 2013 – PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, today announced that Dr. Christine Wilkinson Blanc has joined the company's management team as Chief Medical Officer.
- Date:
- 17/05/2013
- Description
- Serascience Limited, a specialist cancer diagnostics company, announces the launch of SeraliteTM, its proprietary point-of-care diagnostic device for multiple myeloma. The device will initially be available for research use only, followed by CE marking and application for FDA approval.
- Date:
- 15/04/2013
- Description
- Oxford-based The Native Antigen Company (NAC) has received new investment from the Mercia Growth Fund 1 and NAC's existing shareholders.
- Date:
- 02/04/2013
- Description
- Scientists at the University of Birmingham have received funding from the Technology Strategy Board, the UK's innovation agency, to develop a novel multi action siRNA drug with proven neuroprotective and neuroregenerative activity to treat Glaucoma.
- Date:
- 20/03/2013
- Description
- PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
- Date:
- 04/03/2013